Sofie Hædersdal

736 total citations · 1 hit paper
20 papers, 489 citations indexed

About

Sofie Hædersdal is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Sofie Hædersdal has authored 20 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Sofie Hædersdal's work include Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (11 papers) and Diabetes Management and Research (8 papers). Sofie Hædersdal is often cited by papers focused on Diabetes Treatment and Management (13 papers), Pancreatic function and diabetes (11 papers) and Diabetes Management and Research (8 papers). Sofie Hædersdal collaborates with scholars based in Denmark, United States and Iceland. Sofie Hædersdal's co-authors include Filip K. Knop, Tina Vilsbøll, Asger Lund, Andreas Andersen, Jens J. Holst, Anders Junker, Allan M. Lund, Flemming Wibrand, Katrine D. Galsgaard and Nicolai J. Wewer Albrechtsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Sofie Hædersdal

19 papers receiving 480 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

2023 75 citations Sofie Hædersdal, Andreas Andersen et al. Nature Reviews Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sofie Hædersdal Denmark	10	244	222	154	81	76	20	489
Hannes Manell Sweden	10	222 0.9×	177 0.8×	76 0.5×	53 0.7×	112 1.5×	21	433
Kazuhiko Matsuzawa Japan	12	182 0.7×	96 0.4×	158 1.0×	29 0.4×	63 0.8×	30	452
Jun Honjo Japan	12	268 1.1×	202 0.9×	240 1.6×	62 0.8×	81 1.1×	19	634
Luis Concepcion United States	8	157 0.6×	111 0.5×	222 1.4×	45 0.6×	50 0.7×	13	490
Alena Šmahelová Czechia	12	215 0.9×	121 0.5×	86 0.6×	35 0.4×	58 0.8×	42	418
Danfeng Peng China	13	102 0.4×	99 0.4×	115 0.7×	90 1.1×	90 1.2×	36	416
Yasutaka Takeda Japan	9	231 0.9×	181 0.8×	171 1.1×	55 0.7×	73 1.0×	20	454
Maria Lytrivi Belgium	8	169 0.7×	203 0.9×	147 1.0×	78 1.0×	77 1.0×	14	420
Dalia El-Lebedy Egypt	12	95 0.4×	71 0.3×	98 0.6×	61 0.8×	91 1.2×	29	453
T Ahola Finland	10	78 0.3×	80 0.4×	133 0.9×	178 2.2×	44 0.6×	22	432

Countries citing papers authored by Sofie Hædersdal

Since Specialization

Citations

This map shows the geographic impact of Sofie Hædersdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Hædersdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Hædersdal more than expected).

Fields of papers citing papers by Sofie Hædersdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Hædersdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Hædersdal. The network helps show where Sofie Hædersdal may publish in the future.

Co-authorship network of co-authors of Sofie Hædersdal

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Hædersdal. A scholar is included among the top collaborators of Sofie Hædersdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Hædersdal. Sofie Hædersdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, J. Steen, Anne Cathrine B. Thuesen, Jesper Krogh, et al.. (2025). Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 Diabetes. Diabetes Care. 48(9). 1536–1544.

Haugan, Ketil, Claus Graff, Søren Højberg, et al.. (2024). Effects of Atrial Fibrillation Screening According to Thyroid Function: Post Hoc Analysis of the Randomized LOOP Study. The Journal of Clinical Endocrinology & Metabolism. 110(6). e1975–e1984. 1 indexed citations

Hædersdal, Sofie, Andreas Andersen, Filip K. Knop, & Tina Vilsbøll. (2023). Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases. Nature Reviews Endocrinology. 19(6). 321–335. 75 indexed citations breakdown →

Hædersdal, Sofie, Asger Lund, Julie Lyng Forman, et al.. (2022). The glucagon receptor antagonist LY2409021 does not affect gastrointestinal-mediated glucose disposal or the incretin effect in individuals with and without type 2 diabetes. European Journal of Endocrinology. 187(4). 507–518. 3 indexed citations

Hædersdal, Sofie, Asger Lund, Lærke S. Gasbjerg, et al.. (2021). The glucagon receptor antagonist LY2409021 has no effect on postprandial glucose in type 2 diabetes. European Journal of Endocrinology. 186(2). 207–221. 6 indexed citations

Nozaki, Yuichi, Max C. Petersen, Dongyan Zhang, et al.. (2020). Metabolic control analysis of hepatic glycogen synthesis in vivo. Proceedings of the National Academy of Sciences. 117(14). 8166–8176. 64 indexed citations

Christensen, Alexander S., Sofie Hædersdal, Julie Støy, et al.. (2020). Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA). Diabetes Care. 43(9). 2025–2033. 25 indexed citations

Christensen, Alexander S., Sofie Hædersdal, Heidi Storgaard, et al.. (2020). GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers. Diabetes. 69(9). 1989–2002. 16 indexed citations

Hædersdal, Sofie, Asger Lund, Gerrit van Hall, et al.. (2020). The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition. Diabetes. 69(12). 2619–2629. 13 indexed citations

10.

Christensen, Alexander S., Sofie Hædersdal, Heidi Storgaard, et al.. (2019). 981-P: GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in HNF1A Diabetes. Diabetes. 68(Supplement_1). 1 indexed citations

11.

Hædersdal, Sofie, Nicolai J. Wewer Albrechtsen, Asger Lund, et al.. (2019). 1952-P: Glucagon Receptor Antagonism Increases Plasma Amino Acids and Glucagon. Diabetes. 68(Supplement_1). 5 indexed citations

12.

Christensen, Alexander S., Heidi Storgaard, Sofie Hædersdal, et al.. (2018). Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial. BMJ Open. 8(10). e022517–e022517. 7 indexed citations

13.

Hædersdal, Sofie, et al.. (2018). Individual and Combined Glucose-Lowering Effects of Glucagon Receptor Antagonism and Dipeptidyl Peptidase-4 Inhibition. Diabetes. 67(Supplement_1). 1 indexed citations

14.

Hædersdal, Sofie, Asger Lund, Filip K. Knop, & Tina Vilsbøll. (2018). The Role of Glucagon in the Pathophysiology and Treatment of Type 2 Diabetes. Mayo Clinic Proceedings. 93(2). 217–239. 116 indexed citations

15.

Christensen, Alexander S., Heidi Storgaard, Sofie Hædersdal, et al.. (2018). [Diagnosis and treatment of maturity onset diabetes of the young type 3].. PubMed. 180(6). 1 indexed citations

16.

Hædersdal, Sofie, et al.. (2018). Individual and Combined Glucose-Lowering Effects of Glucagon Receptor Antagonism and Sodium-Glucose Cotransporter 2 Inhibition. Diabetes. 67(Supplement_1). 3 indexed citations

17.

Renäult, Kristina M., Emma Malchau Carlsen, Sofie Hædersdal, et al.. (2017). Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers. International Journal of Obesity. 41(4). 598–605. 37 indexed citations

18.

Dziegiel, Morten Hanefeld, Sofie Hædersdal, Angela N. Barrett, et al.. (2017). Blood Chimerism in Dizygotic Monochorionic Twins During 5 Years Observation. American Journal of Transplantation. 17(10). 2728–2732. 9 indexed citations

19.

Albrechtsen, Nicolai J. Wewer, Anders Junker, Mette Christensen, et al.. (2017). Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 314(1). G91–G96. 76 indexed citations

20.

Hædersdal, Sofie, Jannie Dalby Salvig, Martine G. Aabye, et al.. (2013). Inflammatory Markers in the Second Trimester Prior to Clinical Onset of Preeclampsia, Intrauterine Growth Restriction, and Spontaneous Preterm Birth. Inflammation. 36(4). 907–913. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact